AAAAAA

   
Results: 1-15 |
Results: 15
KINETICS OF ANTIVIRAL ACTIVITY BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-SPECIFIC CYTOTOXIC T-LYMPHOCYTES (CTL) AND RAPID SELECTION OF CTL ESCAPE VIRUS IN-VITRO
Authors: VANBAALEN CA SCHUTTEN M HUISMAN RC BOERS PHM GRUTERS RA OSTERHAUS ADME
Citation: Ca. Vanbaalen et al., KINETICS OF ANTIVIRAL ACTIVITY BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-SPECIFIC CYTOTOXIC T-LYMPHOCYTES (CTL) AND RAPID SELECTION OF CTL ESCAPE VIRUS IN-VITRO, Journal of virology, 72(8), 1998, pp. 6851-6857
CORECEPTOR USAGE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 PRIMARY ISOLATES AND BIOLOGICAL CLONES IS BROAD AND DOES NOT CORRELATE WITH THEIR SYNCYTIUM-INDUCING CAPACITIES
Authors: GUILLON C VANDERENDE ME BOERS PHM GRUTERS RA SCHUTTEN M OSTERHAUS ADME
Citation: C. Guillon et al., CORECEPTOR USAGE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 PRIMARY ISOLATES AND BIOLOGICAL CLONES IS BROAD AND DOES NOT CORRELATE WITH THEIR SYNCYTIUM-INDUCING CAPACITIES, Journal of virology, 72(7), 1998, pp. 6260-6263
PHARMACOKINETICS AND ANTI-HIV-1 EFFICACY OF NEGATIVELY CHARGED HUMAN SERUM ALBUMINS IN MICE
Authors: KUIPERS ME SWART PJ SCHUTTEN M SMIT C PROOST JH
Citation: Me. Kuipers et al., PHARMACOKINETICS AND ANTI-HIV-1 EFFICACY OF NEGATIVELY CHARGED HUMAN SERUM ALBUMINS IN MICE, Antiviral research, 33(2), 1997, pp. 99-108
MODULATION OF PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN-MEDIATED ENTRY BY HUMAN-ANTIBODIES
Authors: SCHUTTEN M ANDEWEG AC RIMMELZWAAN GF OSTERHAUS ADME
Citation: M. Schutten et al., MODULATION OF PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN-MEDIATED ENTRY BY HUMAN-ANTIBODIES, Journal of General Virology, 78, 1997, pp. 999-1006
HIV-2 INFECTION IN 12 EUROPEAN RESIDENTS - VIRUS CHARACTERISTICS AND DISEASE PROGRESSION
Authors: VANDERENDE ME SCHUTTEN M LY TD GRUTERS RA OSTERHAUS ADME
Citation: Me. Vanderende et al., HIV-2 INFECTION IN 12 EUROPEAN RESIDENTS - VIRUS CHARACTERISTICS AND DISEASE PROGRESSION, AIDS, 10(14), 1996, pp. 1649-1655
HUMAN-ANTIBODIES THAT NEUTRALIZE PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUSTYPE-1 IN-VITRO DO NOT PROVIDE PROTECTION IN AN IN-VIVO MODEL
Authors: SCHUTTEN M TENNERRACZ K RACZ P VANBEKKUM DW OSTERHAUS ADME
Citation: M. Schutten et al., HUMAN-ANTIBODIES THAT NEUTRALIZE PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUSTYPE-1 IN-VITRO DO NOT PROVIDE PROTECTION IN AN IN-VIVO MODEL, Journal of General Virology, 77, 1996, pp. 1667-1675
ENHANCEMENT OF INFECTIVITY OF A NON-SYNCYTIUM INDUCING HIV-1 BY SCD4 AND BY HUMAN-ANTIBODIES THAT NEUTRALIZE SYNCYTIUM INDUCING HIV-1
Authors: SCHUTTEN M ANDEWEG AC BOSCH ML OSTERHAUS ADME
Citation: M. Schutten et al., ENHANCEMENT OF INFECTIVITY OF A NON-SYNCYTIUM INDUCING HIV-1 BY SCD4 AND BY HUMAN-ANTIBODIES THAT NEUTRALIZE SYNCYTIUM INDUCING HIV-1, Scandinavian journal of immunology, 41(1), 1995, pp. 18-22
CHARACTERIZATION OF A V3 DOMAIN-SPECIFIC NEUTRALIZING HUMAN MONOCLONAL-ANTIBODY THAT PREFERENTIALLY RECOGNIZES NON-SYNCYTIUM-INDUCING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 STRAINS
Authors: SCHUTTEN M LANGEDIJK JPM ANDEWEG AC HUISMAN RC MELOEN RH OSTERHAUS ADME
Citation: M. Schutten et al., CHARACTERIZATION OF A V3 DOMAIN-SPECIFIC NEUTRALIZING HUMAN MONOCLONAL-ANTIBODY THAT PREFERENTIALLY RECOGNIZES NON-SYNCYTIUM-INDUCING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 STRAINS, Journal of General Virology, 76, 1995, pp. 1665-1673
MOLECULAR CHARACTERIZATION OF VARIABLE HEAVY AND LIGHT-CHAIN REGIONS OF 5 HIV TYPE-1-SPECIFIC HUMAN MONOCLONAL-ANTIBODIES
Authors: VANDERDONK EMM SCHUTTEN M OSTERHAUS ADME VANDERHEIJDEN RWJ
Citation: Emm. Vanderdonk et al., MOLECULAR CHARACTERIZATION OF VARIABLE HEAVY AND LIGHT-CHAIN REGIONS OF 5 HIV TYPE-1-SPECIFIC HUMAN MONOCLONAL-ANTIBODIES, AIDS research and human retroviruses, 10(12), 1994, pp. 1639-1649
AN N-GLYCAN WITHIN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 V3 LOOP AFFECTS VIRUS NEUTRALIZATION
Authors: BACK NKT SMIT L DEJONG JJ KEULEN W SCHUTTEN M GOUDSMIT J TERSMETTE M
Citation: Nkt. Back et al., AN N-GLYCAN WITHIN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 V3 LOOP AFFECTS VIRUS NEUTRALIZATION, Virology, 199(2), 1994, pp. 431-438
AN N-GLYCAN WITHIN THE HIV-1 GP120 V3 LOOP IS INVOLVED IN THE MASKINGOF V3-BINDING AND CD4-BINDING NEUTRALIZATION SITES
Authors: BACK NKT SMIT L SCHUTTEN M DEJONG JJ KEULEN W GOUDSMIT J TERSMETTE M
Citation: Nkt. Back et al., AN N-GLYCAN WITHIN THE HIV-1 GP120 V3 LOOP IS INVOLVED IN THE MASKINGOF V3-BINDING AND CD4-BINDING NEUTRALIZATION SITES, Journal of cellular biochemistry, 1993, pp. 25-25
FURTHER CHARACTERIZATION OF AN ANTIGENIC SITE OF HIV-1 GP120 RECOGNIZED BY VIRUS NEUTRALIZING HUMAN MONOCLONAL-ANTIBODIES
Authors: SCHUTTEN M MCKNIGHT A HUISMAN RC THALI M MCKEATING JA SODROSKI J GOUDSMIT J OSTERHAUS AD
Citation: M. Schutten et al., FURTHER CHARACTERIZATION OF AN ANTIGENIC SITE OF HIV-1 GP120 RECOGNIZED BY VIRUS NEUTRALIZING HUMAN MONOCLONAL-ANTIBODIES, AIDS, 7(7), 1993, pp. 919-923
AN IMMUNE-SELECTED POINT MUTATION IN THE TRANSMEMBRANE PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HXB2-ENV-ALA 582(-] THR)) DECREASES VIRAL NEUTRALIZATION BY MONOCLONAL-ANTIBODIES TO THE CD4-BINDING SITE
Authors: KLASSE PJ MCKEATING JA SCHUTTEN M REITZ MS ROBERTGUROFF M
Citation: Pj. Klasse et al., AN IMMUNE-SELECTED POINT MUTATION IN THE TRANSMEMBRANE PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HXB2-ENV-ALA 582(-] THR)) DECREASES VIRAL NEUTRALIZATION BY MONOCLONAL-ANTIBODIES TO THE CD4-BINDING SITE, Virology, 196(1), 1993, pp. 332-337
RESISTANCE OF A HUMAN SERUM-SELECTED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ESCAPE MUTANT TO NEUTRALIZATION BY CD4 BINDING-SITE MONOCLONAL-ANTIBODIES IS CONFERRED BY A SINGLE AMINO-ACID CHANGE IN GP120
Authors: MCKEATING JA BENNETT J ZOLLAPAZNER S SCHUTTEN M ASHELFORD S BROWN AL BALFE P
Citation: Ja. Mckeating et al., RESISTANCE OF A HUMAN SERUM-SELECTED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ESCAPE MUTANT TO NEUTRALIZATION BY CD4 BINDING-SITE MONOCLONAL-ANTIBODIES IS CONFERRED BY A SINGLE AMINO-ACID CHANGE IN GP120, Journal of virology, 67(9), 1993, pp. 5216-5225
MUTATIONS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP41 AFFECT SENSITIVITY TO NEUTRALIZATION BY GP120 ANTIBODIES
Authors: BACK NKT SMIT L SCHUTTEN M NARA PL TERSMETTE M GOUDSMIT J
Citation: Nkt. Back et al., MUTATIONS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP41 AFFECT SENSITIVITY TO NEUTRALIZATION BY GP120 ANTIBODIES, Journal of virology, 67(11), 1993, pp. 6897-6902
Risultati: 1-15 |